Hemodynamic Disruption Triggers Glomerular Barrier Injury via Endothelial Glycocalyx Degradation in Nephrotic Syndrome

Technical Summary: Hemodynamic Disruption Triggers Glomerular Barrier Injury via Endothelial Glycocalyx Degradation in Nephrotic Syndrome

Problem Statement
Nephrotic Syndrome (NS) is clinically characterized by severe proteinuria, generalized edema, and a hypercoagulable state. While the clinical manifestations are well-documented, the mechanistic link between renal microhemodynamic disturbances and injury to the glomerular filtration barrier (GFB) remains poorly defined. Traditional research has predominantly focused on podocyte injury; however, proteinuria can occur even when podocyte foot processes are structurally preserved, suggesting critical involvement of other GFB components. Specifically, the role of the endothelial glycocalyx (EG)—a critical vascular mechanosensor and barrier regulator—in mediating the effects of altered blood flow (hemodynamic disruption) on GFB integrity has been insufficiently studied due to the EG's fragility and nanoscale complexity. Furthermore, the study seeks to bridge the gap between the Traditional Chinese Medicine (TCM) concept of "Unsmooth blood circulation (UBC) results in water retention (WR)" and modern biomedical science by investigating how blood stasis leads to fluid imbalance.

Methodology
The study employed an integrated approach combining in vivo animal models with in vitro microphysiological systems (Organ-on-a-chip):

1. In Vivo Model: An adriamycin (ADR)-induced NS rat model was established. Hemorheological parameters, coagulation function, EG biomarkers (Syndecan-1, Glypican-1, CD44), and urinary metabolites (Hyaluronic Acid and Heparan Sulfate) were monitored. The therapeutic efficacy of sulodexide was evaluated against a prednisone acetate control and an untreated model group.
2. Organ-on-a-Chip (OOC) Platforms:
   • Vascular-on-a-Chip (VOAC): A microfluidic device mimicking human vascular geometry (PDMS channels) seeded with human umbilical vein endothelial cells (HUVECs) to model EG formation under controlled laminar shear stress.
   • Glomerulus-on-a-Chip (GOAC): A dual-layer system with HUVECs in the upper vascular channel and human podocytes in the lower urinary channel, separated by a porous polycarbonate membrane (simulating the glomerular basement membrane). This system was used to assess GFB permeability under varying flow rates.
3. Experimental Conditions: In the OOC systems, cells were exposed to defined fluid shear stresses (FSS) ranging from 0 µL/min (static) to 2 µL/min (physiological) for 24 hours.
4. Analytical Techniques: Transmission electron microscopy (TEM) for ultrastructural analysis, Western blotting and immunofluorescence for protein expression (EG components, adhesion molecules VCAM-1/ICAM-1, cytoskeletal organization), and permeability assays using fluorescent dextran.

Key Contributions

• Integration of TCM and Biomechanics: The study provides a mechanistic interpretation of the TCM theory "UBC→WR" by demonstrating that blood stasis (UBC) leads to reduced shear stress, EG degradation, and subsequent vascular permeability/edema (WR).
• Novel OOC Platform: The development and application of integrated VOAC and GOAC systems allow for the precise isolation of mechanical stimuli (shear stress) from biochemical factors, overcoming limitations of traditional in vitro models that fail to reproduce physiological shear forces.
• Mechanistic Insight: The research identifies EG degradation as a critical bridge between hemodynamic alterations (hypercoagulability/viscosity) and GFB injury, shifting focus toward endothelial mechanobiology in NS pathogenesis.

Results

• Hemodynamic and Coagulation Changes: ADR-induced NS rats exhibited significant hypercoagulability (shortened PT/APTT, elevated fibrinogen) and hemorheological abnormalities (increased whole-blood viscosity and RBC aggregation).
• EG Degradation in NS: In vivo, NS rats showed progressive EG thinning and eventual near-complete disappearance by week 2, accompanied by podocyte fusion and detachment. Urinary excretion of EG components (HS and HA) increased significantly.
• Shear Stress Dependence: In vitro VOAC experiments confirmed that low shear stress (mimicking stasis) triggered EG shedding, cytoskeletal disorganization (loss of stress fibers), and upregulated expression of adhesion molecules (VCAM-1, ICAM-1). Conversely, physiological shear stress (2 µL/min) maintained EG integrity and aligned cytoskeletal structures.
• Barrier Function: In the GOAC model, reduced flow rates correlated with diminished EG and a dose-dependent increase in GFB permeability to dextran.
• Therapeutic Efficacy: Sulodexide treatment effectively protected EG structural integrity, ameliorated hemorheological disorders, and restored microvascular barrier function in NS rats. Notably, sulodexide reduced urinary protein and EG metabolites more effectively than prednisone acetate regarding EG restoration, though both drugs reduced proteinuria.

Significance and Claims
The paper claims that EG degradation is a pivotal pathogenic mechanism linking hemodynamic dysfunction to renal barrier injury in Nephrotic Syndrome. It posits that the "hypercoagulable, viscous" state of NS reduces shear stress, leading to EG loss, which in turn increases vascular permeability and proteinuria. The study validates the utility of Organ-on-a-chip systems as a robust platform for elucidating shear stress-mediated renal dysfunction and integrating traditional medical concepts with modern biomechanics. Finally, it suggests that sulodexide, by targeting EG protection, represents a promising therapeutic strategy for NS, potentially offering benefits beyond standard steroid therapy by addressing the underlying hemodynamic-barrier interface. The authors note that while the study focused on the impact of flow dynamics on EG integrity, the biological roles of exfoliated EG components remain to be elucidated in future work.